ASIA News
At the 79th Annual Scientific Sessions of the American Diabetes Association in San Francisco, pharma giant Roche and India-based digital therapeutics company Wellthy Therapeutics presented real world data of improved diabetes care outcomes in a South Asian population when patients followed prescribed plan of medication and lifestyle modification in conjunction with a combination therapy of self-monitoring blood glucose device and a clinically validated digital therapeutic (DTx).
Ping An Good Doctor, a one-stop healthcare ecosystem platform from China has launched a ‘Private Doctor’ service within their Ping An Good Doctor App.
The term "patient-centric" is often a buzzword or hot topic in the current discussion of healthcare and digital health.
Taiwan-based health tech startup iWEECARE announced that it has raised $1M in Pre-Series A funding, led by Singapore-based Verge HealthTech Fund, alongside Taiwan/US-based Translink Capital and Darwin Venture.
Mumbai-India headquartered digital health start-up Vivant recently launched ‘Nyra’, a simple mobile application that can be used by women to track their period, fertility, ovulation, mood, lifestyle and physical activity.
Last week, AIA, the largest public listed pan-Asian life insurance group, announced a landmark partnership with Medix, a global health management solutions provider that will benefit AIA customers in the Asia Pacific region.
This week at the Cleveland Clinic Patient Experience: Empathy and Innovation Summit, clinicians discussed the international efforts of implementing technology in healthcare.
Ping An Good Doctor, China’s one-stop healthcare ecosystem platform, announced that it will be forming a strategic cooperation with Wyeth Nutrition, a nutrition and health company that is part of the Nestlé Group.
Although health tech and digital health startups have much to offer in terms of transforming healthcare, they often face the challenges of overcoming regulatory hurdles, which are especially stringent in healthcare for the safety of patients.
Also: uBiome's FBI investigation; Better Therapeutics' pivotal trial plans.